BioCardia Inc (BCDA)
NASDAQ
The current BCDA market cap is 10.31M. The company's latest EPS is USD -2.5241 and P/E is -0.87.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 357k | 13k | 55k | 3k | 0 |
Operating Income | -2.6M | -2.08M | -2.28M | -1.65M | -1.76M |
Net Income | -2.57M | -2.07M | -2.27M | -1.65M | -1.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 710k | 145k | 1.02M | 1.35M | 477k |
Operating Income | -14.21M | -15.53M | -12.63M | -11.9M | -11.64M |
Net Income | -14.71M | -15M | -12.62M | -11.91M | -11.57M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.75M | 2.99M | 2.68M | 2.89M | 6.27M |
Total Liabilities | 4.41M | 4.59M | 4.95M | 4.85M | 3.51M |
Total Equity | -660k | -1.6M | -2.28M | -1.96M | 2.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.68M | 23.42M | 15.72M | 9.79M | 2.99M |
Total Liabilities | 5.31M | 4.25M | 5.34M | 4.9M | 4.59M |
Total Equity | 2.37M | 19.18M | 10.38M | 4.89M | -1.6M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.12M | -9.97M | -1.53M | -2.84M | -5.45M |
Investing | -12k | -12k | N/A | -3k | -5k |
Financing | 2.61M | 3.73M | 1.38M | 3.16M | 9.29M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.45M | -12.36M | -10.37M | -10.56M | -9.97M |
Investing | -146k | -32k | -116k | -70k | -12k |
Financing | 9.82M | 28.21M | 1.95M | 5.12M | 3.73M |
Market Cap | 10.31M |
Price to Earnings Ratio | -0.87 |
Price to Sales Ratio | 21.13 |
Price to Cash Ratio | 9.14 |
Price to Book Ratio | -6.29 |
Dividend Yield | - |
Shares Outstanding | 4.58M |
Average Volume (1 week) | 84.51k |
Average Volume (1 Month) | 48.46k |
52 Week Change | -67.18% |
52 Week High | 8.85 |
52 Week Low | 1.625 |
Spread (Intraday) | 0.09 (3.93%) |
Company Name | BioCardia Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.biocardia.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.